458 related articles for article (PubMed ID: 7667182)
1. Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures.
Hancock BC; Shamblin SL; Zografi G
Pharm Res; 1995 Jun; 12(6):799-806. PubMed ID: 7667182
[TBL] [Abstract][Full Text] [Related]
2. Time-dependence of molecular mobility during structural relaxation and its impact on organic amorphous solids: an investigation based on a calorimetric approach.
Mao C; Chamarthy SP; Pinal R
Pharm Res; 2006 Aug; 23(8):1906-17. PubMed ID: 16858653
[TBL] [Abstract][Full Text] [Related]
3. Prediction of the onset of crystallization of amorphous sucrose below the calorimetric glass transition temperature from correlations with mobility.
Bhugra C; Rambhatla S; Bakri A; Duddu SP; Miller DP; Pikal MJ; Lechuga-Ballesteros D
J Pharm Sci; 2007 May; 96(5):1258-69. PubMed ID: 17455303
[TBL] [Abstract][Full Text] [Related]
4. Crystallization of indomethacin from the amorphous state below and above its glass transition temperature.
Yoshioka M; Hancock BC; Zografi G
J Pharm Sci; 1994 Dec; 83(12):1700-5. PubMed ID: 7891297
[TBL] [Abstract][Full Text] [Related]
5. Enthalpy relaxation in binary amorphous mixtures containing sucrose.
Shamblin SL; Zografi G
Pharm Res; 1998 Dec; 15(12):1828-34. PubMed ID: 9892465
[TBL] [Abstract][Full Text] [Related]
6. Predictions of onset of crystallization from experimental relaxation times I-correlation of molecular mobility from temperatures above the glass transition to temperatures below the glass transition.
Bhugra C; Shmeis R; Krill SL; Pikal MJ
Pharm Res; 2006 Oct; 23(10):2277-90. PubMed ID: 16933094
[TBL] [Abstract][Full Text] [Related]
7. Solubility of crystalline organic compounds in high and low molecular weight amorphous matrices above and below the glass transition by zero enthalpy extrapolation.
Amharar Y; Curtin V; Gallagher KH; Healy AM
Int J Pharm; 2014 Sep; 472(1-2):241-7. PubMed ID: 24968139
[TBL] [Abstract][Full Text] [Related]
8. Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization.
Matsumoto T; Zografi G
Pharm Res; 1999 Nov; 16(11):1722-8. PubMed ID: 10571278
[TBL] [Abstract][Full Text] [Related]
9. Determination of the viscosity of an amorphous drug using thermomechanical analysis (TMA).
Hancock BC; Dupuis Y; Thibert R
Pharm Res; 1999 May; 16(5):672-5. PubMed ID: 10350009
[TBL] [Abstract][Full Text] [Related]
10. Dielectric study of the molecular mobility and the isothermal crystallization kinetics of an amorphous pharmaceutical drug substance.
Alie J; Menegotto J; Cardon P; Duplaa H; Caron A; Lacabanne C; Bauer M
J Pharm Sci; 2004 Jan; 93(1):218-33. PubMed ID: 14648651
[TBL] [Abstract][Full Text] [Related]
11. A quantitative assessment of the significance of molecular mobility as a determinant for the stability of lyophilized insulin formulations.
Yoshioka S; Aso Y
Pharm Res; 2005 Aug; 22(8):1358-64. PubMed ID: 16078146
[TBL] [Abstract][Full Text] [Related]
12. Glass fragility and the stability of pharmaceutical preparations--excipient selection.
Hatley RH
Pharm Dev Technol; 1997 Aug; 2(3):257-64. PubMed ID: 9552453
[TBL] [Abstract][Full Text] [Related]
13. The effects of absorbed water on the properties of amorphous mixtures containing sucrose.
Shamblin SL; Zografi G
Pharm Res; 1999 Jul; 16(7):1119-24. PubMed ID: 10450941
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of indomethacin crystallization in poly(vinylpyrrolidone) coprecipitates.
Yoshioka M; Hancock BC; Zografi G
J Pharm Sci; 1995 Aug; 84(8):983-6. PubMed ID: 7500284
[TBL] [Abstract][Full Text] [Related]
15. Glass transition and enthalpy relaxation of amorphous lactose glass.
Haque MK; Kawai K; Suzuki T
Carbohydr Res; 2006 Aug; 341(11):1884-9. PubMed ID: 16709405
[TBL] [Abstract][Full Text] [Related]
16. A calorimetric investigation of thermodynamic and molecular mobility contributions to the physical stability of two pharmaceutical glasses.
Zhou D; Grant DJ; Zhang GG; Law D; Schmitt EA
J Pharm Sci; 2007 Jan; 96(1):71-83. PubMed ID: 17031846
[TBL] [Abstract][Full Text] [Related]
17. Dipolar Reorientations in Amorphous Nimesulide: A TSDC and DSC Study.
Moura Ramos JJ; Diogo HP
Curr Drug Deliv; 2017; 14(1):91-98. PubMed ID: 27160253
[TBL] [Abstract][Full Text] [Related]
18. Molecular relaxation behavior and isothermal crystallization above glass transition temperature of amorphous hesperetin.
Shete G; Khomane KS; Bansal AK
J Pharm Sci; 2014 Jan; 103(1):167-78. PubMed ID: 24186540
[TBL] [Abstract][Full Text] [Related]
19. Effects of molecular weight of polyvinylpyrrolidone on the glass transition and crystallization of co-lyophilized sucrose.
Zeng XM; Martin GP; Marriott C
Int J Pharm; 2001 May; 218(1-2):63-73. PubMed ID: 11337150
[TBL] [Abstract][Full Text] [Related]
20. Coupling between chemical reactivity and structural relaxation in pharmaceutical glasses.
Shamblin SL; Hancock BC; Pikal MJ
Pharm Res; 2006 Oct; 23(10):2254-68. PubMed ID: 16941232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
